The European Journal of Health Economics

2002 - 2025

Current editor(s): J.-M.G.v.d. Schulenburg

From:
Springer
Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ)
Contact information at EDIRC.
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

Access Statistics for this journal.
Is something missing from the series or not right? See the RePEc data check for the archive and series.

Volume 9, issue 4, 2008

Health technology assessment: for whom the bell tolls? pp. 311-312

Livio Garattini and Gianluigi Casadei

Decision-analytical modelling in health-care economic evaluations pp. 313-323

Xin Sun and Thomas Faunce

Discarded cellular components and the technical efficiency of component preparation pp. 325-331

Marketta Veihola, Pekka Aroviita, Riitta Kekomäki, Miika Linna and Harri Sintonen

Nurses’ intentions to leave nursing in Finland pp. 333-342

T. Kankaanranta and P. Rissanen

Lessons for health care reform from the less developed world: the case of the Philippines pp. 343-349

Konrad Obermann, Matthew Jowett, Juanito Taleon and Melinda Mercado

The societal cost of alcohol consumption: an estimation of the economic and human cost including health effects in Sweden, 2002 pp. 351-360

Johan Jarl, Pia Johansson, Antonina Eriksson, Mimmi Eriksson, Ulf-G. Gerdtham, Örjan Hemström, Klara Selin, Leif Lenke, Mats Ramstedt and Robin Room

Cost of care of colorectal cancers according to health care patterns and stage at diagnosis in France pp. 361-367

Laurence Clerc, Valérie Jooste, Catherine Lejeune, Bernard Schmitt, Patrick Arveux, Catherine Quantin, Jean Faivre and Anne-Marie Bouvier

Health insurance theory: the case of the missing welfare gain pp. 369-380

John Nyman

Economic evaluation of innovative technologies in health care should include a short-run perspective pp. 381-384

Eddy Adang

Public funding for community-based skilled delivery care in Indonesia: to what extent are the poor benefiting? pp. 385-392

Tim Ensor, Mardiati Nadjib, Zahid Quayyum and Amila Megraini

Expanding access to primary care without additional budgets? A case study from Burkina Faso pp. 393-403

Paul Marschall and Steffen Flessa

Redistributive effects in public health care financing pp. 405-416

Ivonne Honekamp and Daniel Possenriede

Volume 9, issue 3, 2008

IQWiG: an opportunity lost? pp. 205-207

Bengt Jönsson

Quality of life and cost-effectiveness of acupuncture treatment in patients with osteoarthritis pain pp. 209-219

Thomas Reinhold, Claudia Witt, Susanne Jena, Benno Brinkhaus and Stefan Willich

Economic consequences of near-patient test results: the case of tests for the Helicobacter Pylori bacterium in dyspepsia pp. 221-228

Siri Fauli and Geir Thue

The cost of treating high blood pressure in general practice in France pp. 229-236

Yaël Tibi-Levy, Gérard Pouvourville, Jérémie Westerloppe and Marion Bamberger

An assessment of the discriminative ability of the EQ-5D index, SF-6D, and EQ VAS, using sociodemographic factors and clinical conditions pp. 237-249

Garry Barton, Tracey Sach, Michael Doherty, Anthony Avery, Claire Jenkinson and Kenneth Muir

Estimating the expected value of partial perfect information: a review of methods pp. 251-259

Doug Coyle and Jeremy Oakley

Choice determinants of the mobility in the Dutch health insurance market pp. 261-264

Ilaria Mosca and Anoushka Schut-Welkzijn

Predisposing factors for early retirement in patients with Schizophrenia in Germany pp. 265-274

Reinhard Schnabel, Heiko Friedel, Andreas Erfurth, Matthias Angermayer, Johannes Clouth and Florian Eichmann

Preferences and utilities for the symptoms of moderate to severe allergic asthma pp. 275-284

Andrew Lloyd, Scott Doyle, Sarah Dewilde and Florian Turk

In pursuit of QALY weights for relatives: empirical estimates in relatives caring for older people pp. 285-292

Thomas Davidson, Barbro Krevers and Lars-Åke Levin

A theoretical and empirical investigation of nutritional label use pp. 293-304

Andreas Drichoutis, Panagiotis Lazaridis, Rodolfo Nayga, Maria Kapsokefalou and George Chryssochoidis

Pricing and reimbursement of pharmaceuticals in Italy pp. 305-310

Pietro Folino-Gallo, Simona Montilla, Mario Bruzzone and Nello Martini

Volume 9, issue 2, 2008

The CHESME Health Economic Evaluations Database (CHESME HEED) project pp. 99-101

Dimitrios Rovithis and Lycurgus Liaropoulos

Costing maternal health services in South Tanzania pp. 103-115

Claudia Both, Albrecht Jahn and Steffen Fleßa

Primary physicians’ response to changes in fees pp. 117-125

Jostein Grytten, Fredrik Carlsen and Irene Skau

The search for good compliance: economic aspects of a conveyed combination pharmaco-therapy, exemplified by an osteoporosis therapy pp. 127-136

Peter Oberender and Jürgen Zerth

Methodological issues in undertaking independent cost-effectiveness analysis for NICE: the case of therapies for ADHD pp. 137-145

Susan Griffin, Helen Weatherly, Gerry Richardson and Mike Drummond

The role of non-need factors in individual GP utilisation analysis and their implications for the pursuance of equity: a cross-country comparison pp. 147-156

P. McGregor, P. McKee and C. O’Neill

Eligibility for free GP care, “need” and GP visiting in Ireland pp. 157-163

A. Nolan and B. Nolan

Economic evaluation of the treatment of type 2 diabetes with insulin glargine based on the LAPTOP trial pp. 165-170

Hans Janka and Barbara Högy

Cost utility analysis of early adjuvant letrozole or anastrozole versus tamoxifen in postmenopausal women with early invasive breast cancer: the UK perspective pp. 171-183

Jonathan Karnon, Thomas Delea and Vicki Barghout

The impact of generic substitution on price competition in Finland pp. 185-191

Ville Aalto-Setälä

Spillover of cause-specific longevity interventions: an independent mortality risk model pp. 193-201

Liqun Liu

Pharmacoeconomic evaluation of immunoglobulin treatment in patients with antibody deficiencies from the perspective of the German statutory health insurance pp. 203-203

Barbara Högy, Heinz-Otto Keinecke and Michael Borte

Volume 9, issue 1, 2008

Evidence-based benefit assessment of pharmaceuticals as a basis for rational and economical pharmaceutical therapy pp. 1-3

Thomas Müller

Alcohol consumption in the EU: health economics and policy issues under a permanent debate pp. 1-6

Fernando Antoñanzas, Roberto Rodríguez-Ibeas, Emilio Barco, Manuel Ramírez and Mariola Pinillos

Procedures and methods of benefit assessments for medicines in Germany pp. 5-29

Geertruida Bekkering and Jos Kleijnen

Cost-effectiveness of heptavalent conjugate pneumococcal vaccine (Prevenar) in Germany: considering a high-risk population and herd immunity effects pp. 7-15

Adam Lloyd, Nishma Patel, David Scott, Claus Runge, Christa Claes and Markus Rose

Estimation and comparison of ostomy appliance costs with tariffs in Belgium pp. 17-22

Veerle Vanleene, Luc Maré, Ingrid Moldenaers, Hans Debruyne, Steven Simoens, Dirk Steen and Dirk Ramaekers

Influence of bacterial resistances on the efficiency of antibiotic treatments for community-acquired pneumonia pp. 23-32

Ramon Sabes-Figuera, José Segú, Jaume Puig-Junoy and Antoni Torres

Biostatistical aspects for the use of evidence based medicine in health technology assessment pp. 31-43

Nick Freemantle

Vaccination versus “wait and treat”: how to subsidize them? pp. 33-39

Louis Eeckhoudt, Maurice Marchand, Pierre Pestieau and Gwenael Piaser

The differences in characteristics between health-care users and non-users: implication for introducing community-based health insurance in Burkina Faso pp. 41-50

Hengjin Dong, Adjima Gbangou, Manuela Allegri, Subhash Pokhrel and Rainer Sauerborn

Work environment satisfaction and employee health: panel evidence from Denmark, France and Spain, 1994–2001 pp. 51-61

Nabanita Datta Gupta and Nicolai Kristensen

Does greater exposure to own-health data make a difference on the visual analog scale? pp. 63-67

Amir Shmueli, David Messika, Havi Murad and Laurence Freedman

Willingness to pay for a reduction in mortality risk after a myocardial infarction: an application of the contingent valuation method to the case of eplerenone pp. 69-78

Jose-Luis Pinto-Prades, Veronica Farreras and Jaime de Bobadilla

Factors influencing hospital costs of lung cancer patients in Northern Ireland pp. 79-86

Ian Fleming, Pauline Monaghan, Anna Gavin and Ciaran O’Neill

Pharmaceutical pricing and reimbursement reforms in Greece pp. 87-97

John Yfantopoulos